The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trialJoseph J. Eron, Mark S. Shaefer, Edwin DeJesus et al.|The Lancet|2006Cited by 343
Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 WeeksFederico Pulido, Cristina E. Pharo, Vicente Estrada et al.|HIV Clinical Trials|2009Cited by 32